Loading clinical trials...
Loading clinical trials...
A Phase IV Multicenter Trial to Evaluate Real-world Pharmacoeconomics of Crizotinib and Its Companion Diagnostic Test in Advanced ALK-positive Non-small Cell Lung Cancer (NSCLC) Patients
Conditions
Locations
3
Canada
The Ottawa Hospital
Ottawa, Ontario, Canada
Princess Margaret Hospital
Toronto, Ontario, Canada
CSSS de Rimouski-Neigette
Rimouski, Quebec, Canada
Start Date
February 1, 2015
Primary Completion Date
March 1, 2020
Completion Date
March 1, 2020
Last Updated
March 11, 2020
NCT07250477
NCT06517953
NCT04563338
NCT04163432
NCT04504071
NCT03469960
Lead Sponsor
PeriPharm
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions